Top Regulatory News Stories – Week Ending December 8, 2017
I am posting my regulatory news blog early since I will be out of the office tomorrow. Here are the top regulatory news stories this week: The U.S. FDA approved Mylan’s biosimilar of Roche’s blockbuster treatment for breast cancer, Herceptin. This is the eighth biosimilar to be approved by the FDA: https://www.reuters.com/article/us-mylan-nl-fda/fda-oks-mylans-biosimilar-of-roche-cancer-drug-herceptin-idUSKBN1DV5BI Sunovion received FDA[…]